Log in to search using one of your social media accounts:

 

How to avoid being stressed this holiday season
Holiday stress gets the best of many Americans, but experts explain how to have more merry and less manic this year, whether you're a perfectionist, a family feud-er or just feeling a little lonely. (Source: the Mail online | Health)
Source: the Mail online | Health - November 23, 2017 Category: Consumer Health News Source Type: news

Don't fear the holiday cheer: Avoid stress this season
Holiday stress gets the best of many Americans, but experts explain how to have more merry and less manic this year, whether you're a perfectionist, a family feud-er or just feeling a little lonely. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2017 Category: Consumer Health News Source Type: news

Simple EKG can determine whether patient has depression or bipolar disorder
(Loyola University Health System) A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2017 Category: International Medicine & Public Health Source Type: news

In-Depth: How digital sensors could change the face of pharma
Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka ’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and bipolar disorder. (Source: mobihealthnews)
Source: mobihealthnews - November 17, 2017 Category: Information Technology Source Type: news

Neha Misra Brings Light —and Power—into the Lives of Women around the World
November 15, 2017Neha Misra embodies the notion that unexpected combinations can create unexpected good —a theme that inspires our annual SwitchPoint conference. Meet Neha below and get your tickets to hear her speak atSwitchPoint 2018.Neha Misra is a social entrepreneur, poet, and visual folk artist with a deep belief in the power of human imagination and action to create new realities. She is the co-founder and chief collaboration officer of Solar Sister and a global champion for improving sustainable energy access by advancing women ’s leadership.In 2017, Misra was named a Presidential Leadership S...
Source: IntraHealth International - November 15, 2017 Category: International Medicine & Public Health Authors: intrahealth Source Type: news

Otsuka, Proteus finally win FDA approval for sensor-equipped Abilify
The first drug in the US with a digital ingestion tracking system has been approved by the FDA. The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults. (Source: mobihealthnews)
Source: mobihealthnews - November 14, 2017 Category: Information Technology Source Type: news

FDA approves first trackable pill that syncs with a phone
The FDA approved a pill that tracks when patients take their prescribed psychiatric drug. The medication, Abilify MyCite, is a variation on a drug used to treat schizophrenia and bipolar disorder. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

'Digital Pill' Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news

FDA OKs First 'Digital Pill' That Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news

FDA approves first pill with sensor to track ingestion
The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken. The drug-device combination product is indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes linked with bipolar I disorder and as an add-on treatment for depression in adults. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves first pill with sensor to track ingestion appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Neurological Patient Monitoring Pharmaceuticals Regulatory/Compliance Wall Street Beat Otsuka Pharmaceutical Proteus Digital Health Source Type: news

FDA approves pill with sensor that digitally tracks if patients have ingested their medication
The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 14, 2017 Category: American Health Source Type: news

FDA Approves Pill with Sensor that Digitally Tracks if Patients Have Ingested their Medication
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: eHealth News EU)
Source: eHealth News EU - November 14, 2017 Category: Information Technology Tags: Featured Development Research and Development Source Type: news

FDA approves pill with sensor that digitally tracks if patients have ingested their medication
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: World Pharma News)
Source: World Pharma News - November 14, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder - Leclerc E, Mansur RB, Grassi-Oliveira R, Cordeiro Q, Kapczinski F, McIntyre RS, Brietzke E.
The objective of this study was to investigate the possible association between history of childhood tr... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Man runs 1,250 miles from Colosseum to the London Eye
Dan Keeley, who has bipolar disorder, completed the gruelling 1,250 mile run in aid of a charity. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 9, 2017 Category: Consumer Health News Source Type: news

Genes May Explain Why Some Don't Respond to Bipolar Drug
Title: Genes May Explain Why Some Don't Respond to Bipolar DrugCategory: Health NewsCreated: 11/8/2017 12:00:00 AMLast Editorial Review: 11/9/2017 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - November 9, 2017 Category: Psychiatry Source Type: news

Genes May Explain Why Some Don ’ t Respond to Bipolar Drug
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 8, 2017 Category: Psychiatry Tags: Pharmacy, Psychiatry, Research, News, Source Type: news

Genes May Explain Why Some Don't Respond to Bipolar Drug
Source: HealthDay Related MedlinePlus Pages: Bipolar Disorder, Genes and Gene Therapy, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 8, 2017 Category: Consumer Health News Source Type: news

Genes May Explain Why Some Don't Respond to Bipolar Drug
WEDNESDAY, Nov. 8, 2017 -- In a finding that pulls the roots of two mental illnesses closer together, researchers say people with bipolar disorder that's resistant to the drug lithium have a high number of genes associated with schizophrenia. Since... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 8, 2017 Category: General Medicine Source Type: news

Gene breakthrough on lithium treatment for bipolar disorder
(University of Adelaide) Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the 'gold standard' treatment for bipolar -- the drug lithium -- according to international research led by the University of Adelaide. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Growing Up with a Psychotic Mother
I was ten when my mother had her first psychotic break. It was May. I was looking forward to lazy summer days at the pool, an art camp, a stack of Babysitters Club books, and daydreaming about my first crush, a boy with a splay of freckles and a mop of dark hair. Instead, I was forced to grow up too soon. This meant wearing deodorant and shaving my arm pits. It also meant seeing my mother in a state of complete psychosis, one in which she thought maybe she had killed the postman or the neighbor girl. “I didn’t. Mean. Tokillthepostman.” Her words were all wrong, strung together in a series of hiccups a...
Source: Psych Central - November 6, 2017 Category: Psychiatry Authors: Leslie A. Lindsay Tags: Bipolar Depression Essays Family General Personal Stories Psychology Bipolar Disorder delusions hallucinations Hospitalization involuntary hospitalization Manic Depression Manic Episode Psychosis psychotic mania Source Type: news

Murmurings of a Mad Man: One Man ’ s Mental Health Journey through Creativity
If one has ever been in a psychiatric hospital they are more than aware of the nemesis demon known as ‘boredom’. If one has never been locked up, I don’t believe that a person can really relate. Despite the various groups, listening to the stereo, talking to fellow patients, meals and the most precious visiting hours, one cannot escape the overwhelming dullness that comes to haunt from time to time. Might I make a suggestion that worked for me? Creativity comes from the Creator; you see the similarity of duplicated letters. I believe that every single human being on planet Earth possesses some form of art...
Source: Psych Central - November 4, 2017 Category: Psychiatry Authors: John Kaniecki Tags: Bipolar Creativity Personal Stories Treatment creative outlet Hospitalization Inpatient Treatment Success Stories writing Source Type: news

How an interest in bipolar disorder drugs led to a better understanding of leukemia
(American Society for Biochemistry and Molecular Biology) A research project that began 20 years ago with an interest in how lithium treats mood disorders has yielded insights into the progression of blood cancers such as leukemia. The research, which centers on a protein called GSK-3, will be published in the Nov. 3 issue of the Journal of Biological Chemistry. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2017 Category: International Medicine & Public Health Source Type: news

Renal concerns relative to the use of lithium in geriatric bipolar disorder patients - Szpunar J, Maeshima H, Grossberg GT.
BACKGROUND: Lithium is a first-line treatment for bipolar disorder in geriatric patients; however, it has long been associated with potentially significant renal consequences, including chronic kidney disease (CKD). METHODS: We reviewed the availab... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Self-harm, affective traits, and psychosocial functioning in adults with depressive and bipolar disorders - Weintraub MJ, Van de Loo MM, Gitlin MJ, Miklowitz DJ.
Self-harm refers to the purposeful destruction of bodily tissue without suicidal intention and for purposes that are not socially sanctioned. Little is known about the associations between a history of self-harm, mood symptoms, and functioning in adults wi... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Psychiatric Disorders Linked to Progression in MS Psychiatric Disorders Linked to Progression in MS
Among 2300 patients with MS, any psychiatric comorbidity was associated with greater MS disability progression, as was depression -- but not anxiety or bipolar disorder.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Ties: When the Make-Believe World Is All too Real
I suspected my wife wasn ’ t going to join me and my son for Halloween because, once again, she was going psychotic. (Source: NYT Health)
Source: NYT Health - October 27, 2017 Category: Consumer Health News Authors: MARK LUKACH Tags: Halloween Costumes Bipolar Disorder Families and Family Life Parenting Source Type: news

Child- and family-focused cognitive behavioral therapy for pediatric bipolar disorder: applications for suicide prevention - Weinstein SM, Cruz RA, Isaia AR, Peters AT, West AE.
Despite high rates of suicide ideation (SI) and behavior in youth with pediatric bipolar disorder (PBD), little work has examined how psychosocial interventions impact suicidality among this high-risk group. The current study examined SI outcomes in a rand... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Feasibility of the Korean version of the Bipolar Depression Rating Scale in adolescents with early-onset bipolar disorder - Lee DY, Won EK, Choi JW, Min HJ, Kim J, Ha K, Lee Y, Chang JS, Kim Y.
This study explores the feasibility and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS) in adolescents with Early-onset bipolar disorders. METHODS: Fifty-three participants (aged 13-18) with ea... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Brain Training Boosts Cognition in Bipolar Disorder Brain Training Boosts Cognition in Bipolar Disorder
A computer-based cognitive training program improved cognitive function in patients with bipolar disorder, with results that lasted beyond the training period.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 20, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

People with and without mental health conditions receive preventive care at similar rates
(Kaiser Permanente) People with schizophrenia and bipolar disorder received preventive health screenings at rates similar to or higher than people without mental illnesses, according to a study of more than 800,000 patients published today in the American Journal of Preventive Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

Why It's Time To Stop Casually Calling People'Schizophrenic' And'Bipolar '
It’s a problem that’s evident even without leaving the world of politics. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 18, 2017 Category: Consumer Health News Source Type: news

Bright White Light Therapy Promising for Bipolar Depression
Midday bright light sessions associated with higher remission rate than dim red placebo light treatment (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 16, 2017 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Psychiatry, Journal, Source Type: news

Medical News Today: What is psychomotor agitation?
Psychomotor agitation can cause a person to make movements without meaning to. It is a symptom of several conditions, including bipolar disorder. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 16, 2017 Category: Consumer Health News Tags: Bipolar Source Type: news

A survey on the attitude towards renaming bipolar disorder in Japanese - Kato T, Kanba S.
For the revision of the International Statistical Classification of Diseases and Related Health Problems (ICD)-10 into the ICD-11, the Liaison Committee of Psychiatric Disease Names of Japanese Society of Psychiatry and Neurology concluded that "disorder" ... (Source: SafetyLit)
Source: SafetyLit - October 14, 2017 Category: International Medicine & Public Health Tags: Commentary Source Type: news

'Light therapy' may offer relief to patients with bipolar disorder
People afflicted with bipolar disorder may find some relief from depression with daily doses of light therapy, new research suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2017 Category: Consumer Health News Source Type: news

Light Therapy May Help Some With Bipolar Disorder
Study found an hour in front of a light box helped ease depressive symptoms (Source: WebMD Health)
Source: WebMD Health - October 12, 2017 Category: Consumer Health News Source Type: news

Daily ‘ Light Therapy ’ May Help Some With Bipolar Disorder
Study found an hour in front of a light box helped ease depressive symptoms (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 12, 2017 Category: Psychiatry Tags: Neurology, Nursing, Psychiatry, News, Source Type: news

Daily'Light Therapy' May Help Some with Bipolar Disorder
Study found an hour in front of a light box helped ease depressive symptoms Source: HealthDay Related MedlinePlus Pages: Bipolar Disorder (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 12, 2017 Category: Consumer Health News Source Type: news

Woman was denied travel insurance due to bipolar disorder
Elizabeth Watson, 29, from London, was granted travel insurance from the company, which was then cancelled after she later mentioned she suffered from the mental health condition. (Source: the Mail online | Health)
Source: the Mail online | Health - October 12, 2017 Category: Consumer Health News Source Type: news

Daily'Light Therapy' May Help Some With Bipolar Disorder
THURSDAY, Oct. 12, 2017 -- People afflicted with bipolar disorder may find some relief from depression with daily doses of light therapy, new research suggests. With light therapy, people spend time sitting in close proximity to a light-emitting... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 12, 2017 Category: General Medicine Source Type: news

'I was stopped from working because of my bipolar'
Ross' employer sent him a letter when he was off sick and feeling suicidal, and he says it "nearly pushed him off the edge". (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 10, 2017 Category: Consumer Health News Source Type: news

Bright light therapy at midday helped patients with bipolar depression
(Northwestern University) Daily exposure to bright white light at midday significantly decreased symptoms of depression and increased functioning in people with bipolar disorder, a recent Northwestern Medicine study found. More than 68 percent of patients who received midday bright light achieved a normal level of mood, compared to 22.2 percent of patients who received a dim placebo light. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2017 Category: International Medicine & Public Health Source Type: news

Bright Light Therapy Improves Bipolar Depression Bright Light Therapy Improves Bipolar Depression
Portable and easy to use, light therapy may be an option for patients with an inadequate response to antidepressants or who experience side effects from these medications.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 9, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Risks of road injuries in patients with bipolar disorder and associations with drug treatments: a population-based matched cohort study - Chen VC, Yang YH, Lee CP, Wong J, Ponton L, Lee Y, McIntyre RS, Huang KY, Wu SI.
OBJECTIVE: Using a nation-wide, population-based dataset, we aimed to investigate the risk of road injury among individuals with bipolar disorder (BD) compared to individuals without BD. In addition, we investigated the putative moderating effects of presc... (Source: SafetyLit)
Source: SafetyLit - October 5, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Dysfunctional gaze processing in bipolar disorder - Berchio C, Piguet C, Michel CM, Cordera P, Rihs TA, Dayer AG, Aubry JM.
Gaze conveys emotional information, and humans present sensitivity to its direction from the earliest days of life. Bipolar disorder is a disease characterized by fluctuating states of emotional and cognitive dysregulation. To explore the role of attention... (Source: SafetyLit)
Source: SafetyLit - October 5, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Your NEJM Group Today: Gun Control Editorial / Noontime Light for Bipolar Depression / Kentucky Gastroenterology Opportunity (FREE)
By the Editors Take a look at today's offering from NEJM Group: New England Journal of Medicine: The Journal's editors ask: " For … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 4, 2017 Category: Primary Care Source Type: news

Ancient remedy crushes “breakthrough” depression drug
Two breakthrough treatments for depression have been making headlines over the last few weeks. One is ketamine — an illegal party drug called “Special K.” There is a legal use for it — as a heavy-duty anesthetic for horses! Although it seems to work for some severely depressed people, the doctors prescribing it have no idea how or why it works, or what the long-term effects will be for the patients who take it. What we do know is that chronic use of ketamine has been linked to cognitive impairment and bladder inflammation. Taking too high a dose causes hallucinations and temporary paralysis. A keta...
Source: Al Sears, MD Natural Remedies - October 3, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Brain Health depression drugs relax yoga Source Type: news

Cheryl Strayed: Someday, a Woman Like Hillary Clinton Will Win
My kids didn’t have school the day after Donald Trump won the presidential election and eventually, near noon, they came into my room to see what was wrong with me. Perhaps they’d come to me at their father’s prompting. Perhaps they’d heard me weeping. They’d never seen me this way before. Inconsolable. “Hillary didn’t lose!” I insisted, as they sat on the bed around me, even as Hillary’s voice drifted into the room — her concession speech, on the radio downstairs, my husband shouting up, “Honey, you should come listen to this!” I would not listen. I w...
Source: TIME.com: Top Science and Health Stories - October 3, 2017 Category: Consumer Health News Authors: Cheryl Strayed Tags: Uncategorized Books Source Type: news

Olanzapine Has Lower Benefit-to-Risk Ratio in Less Severe Bipolar I Olanzapine Has Lower Benefit-to-Risk Ratio in Less Severe Bipolar I
Patients with less-severe bipolar I disorder benefit less from olanzapine than do those with more-severe disease, but both groups experience the same side effects, according to a new meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news